We have carried out a (high-throughput) screening of 30 000 low molecular substances against our target protein. One of the substances showed activity and selectivity on our target protein. After a silico-design, substances with 10 times high potency were found. We are not looking for a CRO that can help us with furthering development of our substances to improve pharmacology and toxicology properties.
Frist
Fristen for mottak av tilbud var 2018-08-13.
Anskaffelsen ble publisert 2018-07-12.
Kunngjøring av konkurranse (2018-07-12) Gjenstand Anskaffelsens omfang
Tittel: Research and development services and related consultancy services
Referansenummer: ANSK-0531-18
Kort beskrivelse:
“We have carried out a (high-throughput) screening of 30 000 low molecular substances against our target protein. One of the substances showed activity and...”
Kort beskrivelse
We have carried out a (high-throughput) screening of 30 000 low molecular substances against our target protein. One of the substances showed activity and selectivity on our target protein. After a silico-design, substances with 10 times high potency were found. We are not looking for a CRO that can help us with furthering development of our substances to improve pharmacology and toxicology properties.
Vis mer Metadata for kunngjøring
Originalspråk: engelsk 🗣️
Dokumenttype: Kunngjøring av konkurranse
Kontraktens art: Tjenester
Forskrift: Det europeiske økonomiske samarbeidsområdet (EØS), med deltakelse av GPA-land
Felles innkjøpsordliste (CPV)
Kode: Forsknings- og utviklingsvirksomhet og tilhørende konsulenttjenester📦
Tilleggs-CPV: Laboratorietjenester📦 Utførelsessted
NUTS-region: no011 🏙️
Prosedyre
Prosedyretype: Konkurranse med forhandling
Tilbudstype: Innlevering for alle delkontrakter
Tildelingskriterier
Det mest økonomisk fordelaktige tilbudet
Kunngjøring om tildeling av kontrakt (2018-11-13) Gjenstand Anskaffelsens omfang
Kort beskrivelse:
“We have carried out a (high-throughput) screening of 30 000 low molecular substances against our target protein. One of the substances showed activity and...”
Kort beskrivelse
We have carried out a (high-throughput) screening of 30 000 low molecular substances against our target protein. One of the substances showed activity and selectivity on our target protein. After a silico-design, substances with ten times high potency were found. We are not looking for a CRO that can help us with furthering development of our substances to improve pharmacology and toxicology properties.
Vis mer
Totalverdi for anskaffelsen: 3 500 000 NOK 💰
Metadata for kunngjøring
Dokumenttype: Kunngjøring om tildeling av kontrakt